Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Flora Growth Corp. (7301.F)

Compare
0.7850
-0.0150
(-1.87%)
As of 8:07:32 AM GMT+1. Market Open.
Loading Chart for 7301.F
DELL
  • Previous Close 0.8000
  • Open 0.7850
  • Bid 0.8100 x --
  • Ask 0.8700 x --
  • Day's Range 0.7850 - 0.7850
  • 52 Week Range 0.6900 - 1.8600
  • Volume 4
  • Avg. Volume 39
  • Market Cap (intraday) 15.254M
  • Beta (5Y Monthly) 2.00
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

www.floragrowth.com

97

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7301.F

View More

Performance Overview: 7301.F

Trailing total returns as of 2/24/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

7301.F
15.14%
S&P 500
2.46%

1-Year Return

7301.F
21.50%
S&P 500
18.42%

3-Year Return

7301.F
21.50%
S&P 500
40.51%

5-Year Return

7301.F
21.50%
S&P 500
86.81%

Compare To: 7301.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7301.F

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    15.12M

  • Enterprise Value

    16.15M

  • Trailing P/E

    --

  • Forward P/E

    12.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.14

  • Price/Book (mrq)

    3.60

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.99%

  • Return on Assets (ttm)

    -22.30%

  • Return on Equity (ttm)

    -185.18%

  • Revenue (ttm)

    64.15M

  • Net Income Avi to Common (ttm)

    -18M

  • Diluted EPS (ttm)

    -1.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.21M

  • Total Debt/Equity (mrq)

    102.18%

  • Levered Free Cash Flow (ttm)

    451.25k

Research Analysis: 7301.F

View More

Company Insights: 7301.F

Research Reports: 7301.F

View More